Related Experiment Videos
Neuroprotection for Parkinson's disease: a call for clinically driven experimental design
1Basal Gang, Laboratoire de Neurophysiologie, CNRS UMR 5543, Université Victor Segalen, 33076, Bordeaux, France. erwan.bezard@umr5543.u-bordeaux2.fr <erwan.bezard@umr5543.u-bordeaux2.fr>
The Lancet. Neurology
|July 10, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A small molecule reduces both parkinsonism and l-dopa-induced dyskinesia in animal models of Parkinson's disease.
Science translational medicine·2026
High-Fat Diet Exacerbates Neuropathology in a Transgenic Mouse Model of Multiple System Atrophy.
Movement disorders : official journal of the Movement Disorder Society·2026
Report of the scientific network Holimitox on succinate dehydrogenase inhibitor (SDHI) pesticides: new insights and challenges with an EcoHealth approach-presentations and round tables from the Holimitox day on November 7, 2024.
Environmental science and pollution research international·2026
Shared and distinct lipid profiles in amygdala from sporadic and GBA-associated Parkinson's diseases.
NPJ Parkinson's disease·2026
WDR44 drives de novo α-synuclein aggregation at the lysosomal membrane and promotes neuronal dysfunction in Parkinson's Disease.
bioRxiv : the preprint server for biology·2026
Cholinesterase inhibitors in people with dementia with Lewy bodies and cardiac conduction abnormalities.
The Lancet. Neurology·2026
Advances in chronic subdural haematoma management: beyond the burr hole.
The Lancet. Neurology·2026
Exploring the Molecular Mechanisms of SB216763 in the Therapeutic Intervention of Pulmonary Fibrosis Based on Macrophage Functional Plasticity.
Fundamental & clinical pharmacology·2026
Pharmacologic Strategies for Anemia in Patient Blood Management: A Systematic Review and Practical Clinical Synthesis.
The Annals of pharmacotherapy·2026
Utilization patterns of second-generation androgen receptor pathway inhibitors as first-line therapy for prostate cancer in the United States.
Prostate cancer and prostatic diseases·2026
Clinical Approach to Impulse Control-Related Behavioral Disorders in Parkinson's Disease: A Scoping Review.
Movement disorders clinical practice·2026